These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15793608)

  • 21. A clampless and sutureless aortic anastomosis technique using an endograft connector for aortoiliac occlusive disease in which the aorta cannot be clamped or sewn due to calcification or scarring.
    Papadimitriou D; Mayer D; Lachat M; Pecoraro F; Frauenfelder T; Pfammatter T; Ueda H; Donas K; Veith FJ; Rancic Z
    Vascular; 2012 Oct; 20(5):262-7. PubMed ID: 22983546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic concurrence of coronary artery disease and aortoiliac lesions.
    Rangel A; Albarrán H; Solorio S; Hernández-González MA
    Angiology; 2002; 53(6):685-92. PubMed ID: 12463622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duplex ultrasound scanning for diagnosis of aortoiliac and femoropopliteal arterial disease.
    Karacagil S; Lofberg AM; Almgren B; Granbo A; Jonsson ML; Lorelius LE; Bergqvist D
    Vasa; 1994; 23(4):325-9. PubMed ID: 7817613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrarenal aortic dilatation less than 4 cm is not unusual in patients with aortoiliac occlusive disease.
    Matsushita M; Nishikimi N; Sakurai T; Nimura Y
    Int Angiol; 2002 Sep; 21(3):222-7. PubMed ID: 12384641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F
    Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.
    Raggi P; Callister TQ; Davidson M; Welty FK; Bachmann GA; Laskey R; Pittman D; Kafonek S; Scott R
    Am Heart J; 2001 May; 141(5):722-6. PubMed ID: 11320358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.
    Rodés-Cabau J; Facta A; Larose E; DeLarochellière R; Déry JP; Nguyen CM; Roy L; Proulx G; Gleeton O; Barbeau G; Noël B; Rouleau J; Boudreault JR; Bertrand OF
    Am J Cardiol; 2007 Aug; 100(4):640-5. PubMed ID: 17697821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in arterial stiffness during hypolipidaemic therapy is offset by weight gain.
    Matthews PG; Wahlqvist ML; Marks SJ; Myers KA; Hodgson JM
    Int J Obes Relat Metab Disord; 1993 Oct; 17(10):579-83. PubMed ID: 8242126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
    Hoogwerf BJ; Waness A; Cressman M; Canner J; Campeau L; Domanski M; Geller N; Herd A; Hickey A; Hunninghake DB; Knatterud GL; White C
    Diabetes; 1999 Jun; 48(6):1289-94. PubMed ID: 10342818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of lipid lowering in coronary artery disease.
    Goldberg AC
    Curr Opin Cardiol; 1997 Sep; 12(5):488-93. PubMed ID: 9352177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
    Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
    Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting iliac limb occlusions after bifurcated aortic stent grafting: anatomic and device-related causes.
    Carroccio A; Faries PL; Morrissey NJ; Teodorescu V; Burks JA; Gravereaux EC; Hollier LH; Marin ML
    J Vasc Surg; 2002 Oct; 36(4):679-84. PubMed ID: 12368725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.